The bill proposed repealing sections about who serves on South Dakota’s medical cannabis oversight committee and what it reviews, but the Senate rejected it.
The bill proposed repealing sections about the medical cannabis oversight committee, its members, and its review duties. The Senate rejected the bill on March 9, 2026, so the proposed repeals did not pass.
The introduced bill proposed repealing three sections that describe the medical cannabis oversight committee. The sections describe the committee’s members, leadership, and review duties, including reviewing patient access, cannabis facilities, safety rules, research, and other program matters. The proposed repeals appear in the introduced bill. The Senate rejected the bill on March 9, 2026.
No hearings or votes scheduled.